Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Lilly's profit doubled in the fourth quarter, driven by its diabetes and obesity treatments Mounjaro and Zepbound, while ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

D.R. ANSWER: A 2023 trial by the manufacturer of Ozempic, Wegovy and Rybelsus found that a 50-mg daily oral dose was ... Tirzepatide (Mounjaro and Zepbound) is not available as an oral agent ...

How much protein do I need to eat with Mounjaro? Experts recommend about 10–35% of your daily calories should come from protein. For most people, this equates to a minimum of 0.8 grams of ...

How much protein do I need to eat with Mounjaro? Experts recommend about 10–35% of your daily calories should come from protein. For most people, this equates to a minimum of 0.8 grams of protein per ...